Acrivon Therapeutics share price today

(ACRV)

Acrivon Therapeutics share price is $6.79 & ₹582.65 as on 7 Jan 2025, 2.30 'hrs' IST

$6.79

▲

0.17

(2.57%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Acrivon Therapeutics share price in Dollar and Rupees. Guide to invest in Acrivon Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Acrivon Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Acrivon Therapeutics share price movements

Today's Low: $6.48
Today's High: $7.12
$6.79
4.57%
Downside
Day's Volatility :8.99%
Upside
4.63%
52 Weeks Low: $3.19
52 Weeks High: $11.90
$6.79
53.02%
Downside
52 Weeks Volatility :73.19%
Upside
42.94%

Acrivon Therapeutics Returns

Period	Acrivon Therapeutics, Inc.	Index (Russel 2000)
3 Months	-5.43%	0.0%
6 Months	-7.15%	0.0%
1 Year	57.62%	0.0%
3 Years	-60.22%	-19.8%

Acrivon Therapeutics Key Statistics

in dollars & INR

Previous Close	$6.62
Open	$6.7
Today's High	$7.12
Today's Low	$6.48
Market Capitalization	$187.4M
Today's Volume	$69.8K
52 Week High	$11.9
52 Week Low	$3.19
Revenue TTM	$0.0
EBITDA	$-75.6M
Earnings Per Share (EPS)	$-2.66
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.78%

How to invest in Acrivon Therapeutics from India?

It is very easy for Indian residents to invest directly in Acrivon Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Acrivon Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Acrivon Therapeutics or ACRV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Acrivon Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Acrivon Therapeutics shares which would translate to 0.126 fractional shares of Acrivon Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Acrivon Therapeutics, in just a few clicks!

Returns in Acrivon Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Acrivon Therapeutics investment value today

Current value as on today

₹1,64,889

Returns

₹64,889

(+64.89%)

Returns from Acrivon Therapeutics Stock

₹61,667 (+61.67%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Acrivon Therapeutics

-50%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Acrivon Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -50% less investors are searching Acrivon Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Acrivon Therapeutics

RA Capital Management, LLC
26.79%
Perceptive Advisors LLC
17.22%
Citadel Advisors Llc
6.88%
Sands Capital Ventures, LLC
6.82%
Wellington Management Company LLP
2.85%
Marshall Wace Asset Management Ltd
2.60%

Analyst Recommendation on Acrivon Therapeutics

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Acrivon Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Acrivon Therapeutics

What analysts predicted

Upside of 210.91%

Current:

$6.79

Target:

$21.11

Insights on Acrivon Therapeutics

Price Movement
In the last 7 days, ACRV stock has moved up by 22.4%

Acrivon Therapeutics Technicals Summary

Sell

Neutral

Buy

Acrivon Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Acrivon Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Acrivon Therapeutics, Inc.	-0.45%	-7.15%	57.62%	-60.22%	-60.22%
Regeneron Pharmaceuticals, Inc.	-8.86%	-31.87%	-20.46%	15.59%	87.28%
Biontech Se	-4.16%	43.82%	3.49%	-49.66%	167.6%
Alnylam Pharmaceuticals, Inc.	-8.45%	-8.03%	19.03%	56.02%	98.44%
Vertex Pharmaceuticals Incorporated	-14.11%	-16.23%	-2.87%	81.78%	76.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Acrivon Therapeutics, Inc.	NA	NA	NA	-2.63	-0.38	-0.24	NA	5.38
Regeneron Pharmaceuticals, Inc.	17.61	17.61	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Acrivon Therapeutics, Inc.	Buy	$187.4M	-60.22%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.3B	87.28%	17.61	33.61%
Biontech Se	Buy	$27.3B	167.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	98.44%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$103.7B	76.8%	32.84	-4.51%

About Acrivon Therapeutics

acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the foundational science is based on proven, pathway-based methods linking active disease-driving mechanisms with the drug mechanism-of-action, to precisely match the therapy with patients who will benefit. our method is applicable across drug modalities

Organization	Acrivon Therapeutics
Employees	58
CEO	Dr. Peter Blume-Jensen M.D., Ph.D.
Industry	Healthcare

Management People of Acrivon Therapeutics

Name	Title
Dr. Peter Blume-Jensen M.D., Ph.D.	Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
Ms. Kristina Masson M.B.A., Ph.D.	Co-Founder, Executive VP of Business Operations, Site Head, Treasurer, Secretary & Director
Ms. Mary-Alice Miller J.D.	Chief Legal Officer
Mr. Rasmus Holm-Jorgensen	Chief Financial Officer
Dr. Eric J. Devroe Ph.D.	Chief Operating Officer
Ms. Katharine Peterson CPA	Vice President of Finance & Accounting
Dr. Adam D. Levy M.B.A., Ph.D.	Senior VP and Head of Investor Relations & Corporate Affairs
Mr. Bruce Close	Vice President of Quality & Compliance
Ms. Parvin Miah	VP & Head of Human Resources
Dr. Erick Gamelin M.D., Ph.D.	Chief Development Officer

Important FAQs about investing in Acrivon Therapeutics from India :

What is Acrivon Therapeutics share price today?

Acrivon Therapeutics share price today stands at $6.79, Open: $6.70 ; Previous Close: $6.62 ; High: $7.12 ; Low: $6.48 ; 52 Week High: $11.90 ; 52 Week Low: $3.19. The stock opens at $6.70, after a previous close of $6.62. The stock reached a daily high of $7.12 and a low of $6.48, with a 52-week high of $11.90 and a 52-week low of $3.19.

Can Indians buy Acrivon Therapeutics shares?

Yes, Indians can invest in the Acrivon Therapeutics (ACRV) from India.

With INDmoney, you can buy Acrivon Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Acrivon Therapeutics at zero transaction cost.

How can I buy Acrivon Therapeutics shares from India?

It is very easy to buy Acrivon Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Acrivon Therapeutics be purchased?

Yes, you can buy fractional shares of Acrivon Therapeutics with INDmoney app.

What are the documents required to start investing in Acrivon Therapeutics stocks?

To start investing in Acrivon Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.